DALLAS, May 11, 2026 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today issued a statement regarding the conviction of the Company’s former Chairman and CEO, Brad Heppner, by a federal jury in the United States District Court for the Southern District of New York (“SNDY”) on charges of securities fraud, wire fraud, conspiracy to commit securities fraud and wire fraud, and false statements to auditors in connection with a scheme to defraud GWG Holdings, Inc. As established at trial, Mr. Heppner acted solely on behalf of his family office to perpetrate this scheme through a shell company he controlled. See here for SDNY’s press release announcing the verdict. As...

Vancouver, BC, May 11, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X450) (“Deep Sea Minerals” or the “Company”), a subsea mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, is pleased to recap its participation at the 2026 Offshore Technology Conference (“OTC”), held May 4 – 7, 2026, at the NRG Center in Houston, Texas. Deep Sea Minerals was represented at the conference by James Deckelman, Chief Executive Officer, and Dan McConnell, Vice President of Exploration. Mr. McConnell also serves as Chair of the OTC Board of Directors, reflecting the Company’s continued engagement with the broader offshore technology and marine resources community. OTC 2026 brought together offshore energy, marine technology, government,...

Collaboration expected to accelerate Robotics-as-a-Service growth strategy across hospitality, logistics, healthcare, and commercial automation markets LOS ANGELES, May 11, 2026 (GLOBE NEWSWIRE) — via IBN – Nightfood Holdings, Inc. (OTCQB: NGTF) (“Nightfood” or the “Company”), operating through its TechForce Robotics division, today announced a strategic partnership initiative with ToDo Robotics, an established robotics deployment and integration company that has completed more than 300 robotic system deployments since inception, as Nightfood continues expanding its national AI-powered automation and Robotics-as-a-Service (“RaaS”) platform across high-growth commercial markets. The collaboration is designed to accelerate TechForce Robotics’ commercial expansion strategy by combining the Company’s AI-powered robotics ecosystem, autonomous...

MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028 DALLAS, May 11, 2026 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” “QLE” or the “Company”), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has entered into a non-binding Memorandum of Understanding (MOU) with a European nuclear technology company specializing in advanced nuclear reactor development and other next-generation nuclear energy solutions. “Securing reliable HALEU supply is one of the most critical challenges facing the advanced nuclear industry today. This MOU is a meaningful step in QLE’s mission to build...

ROE triples its manufacturing capacity for high-precision, multi-material monolithic dentures, capitalizing on early success with the NextDent® 300 jetted-denture solution to meet accelerating U.S. demand. Expansion highlights rapid commercial adoption of 3D Systems’ industry-first multi-material Jetted Denture Solution. Reinforces 3D Systems’ leadership in digital dentistry as labs shift from conventional methods to scalable, high-margin digital workflows.ROCK HILL, S.C., May 11, 2026 (GLOBE NEWSWIRE) — 3D Systems (NYSE: DDD) today announced that ROE Dental Laboratory, one of the nation’s premier full-service dental labs, has purchased additional NextDent® 300 3D printers to expand its digital denture manufacturing capacity. With multiple systems in multiple locations now coming online, ROE becomes the leading dental laboratory...

– Positive pre-BLA meeting completed with FDA for z-rostudirsen in exon 51 DMD; on track for BLA submission in Q2 2026 and potential launch in Q1 2027 – – Positive cardiopulmonary results and long-term dystrophin data from Phase 1/2 DELIVER trial of z-rostudirsen in exon 51 DMD presented at MDA conference – – Completion of enrollment in registrational expansion cohort of Phase 1/2 ACHIEVE trial of z-basivarsen in DM1 on track for Q2 2026; global confirmatory Phase 3 HARMONIA trial initiated – – New preclinical data to be presented at ASGCT underscore differentiated capability of clinically validated FORCETM platform to cross the blood-brain barrier – WALTHAM, Mass., May 11, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering...

– Peer-reviewed study from the bioMUSE Natural History Study shows advanced MRI method detects disease-specific iron accumulation that supports diagnosis and correlates with clinical severity in patients with Multiple System Atrophy (MSA) –  – Findings support QSM as an objective imaging biomarker to enable earlier diagnosis and assess iron-modulating therapies in MSA, including Alterity’s lead candidate ATH434 – MELBOURNE, Australia and SAN FRANCISCO, May 11, 2026 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the publication of a peer-reviewed study in NeuroImage, a leading journal in human brain imaging, demonstrating that quantitative susceptibility mapping...

4basebio PLC (“4basebio” or the “Company”) 4basebio Launches Enzymatic ssDNA PlatformOvercomes critical manufacturing and performance bottlenecks associated with traditional chemical synthesis, providing faster and more reliable ssDNA manufacturing to aid commercial scale up 4basebio team to present at ASGCT Annual Meeting 2026 in Boston, MACAMBRIDGE, UK – 11 May 2026 – 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the commercial launch of its high-capacity single-stranded DNA (ssDNA) product line to accelerate the development of safer, more precise genetic therapies by enabling targeted gene editing, advanced cell engineering, and innovative nucleic acid-based medicines. Built on a proprietary enzymatic manufacturing process,...

RICHMOND, Va., May 11, 2026 (GLOBE NEWSWIRE) — ARKO Petroleum Corp. (Nasdaq: APC) (“APC” or the “Company”), one of the largest wholesale fuel distributors in the United States, today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Key Highlights (vs. Year-Ago Period) 1,2Net income for the quarter increased to $8.1 million compared to $4.5 million. Adjusted EBITDA for the quarter increased to $36.4 million compared to $30.9 million. Net cash provided by operating activities for the quarter was $6.6 million compared to $14.9 million. Discretionary Cash Flow for the quarter was $25.0 million compared to $17.1 million. Total debt, net was $184.5 million and Net Debt was $313.5 million, in each case, as of March 31, 2026.Other Key HighlightsThe Company completed its initial public offering...